Plasma lipoproteins, apoproteins and cardiovascular disease in Type 2 diabetic patients. A nine-year follow-up study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 13, Issue 1, 2003, Pages 46-51

  Della Rovere, G Roselli ^a   Lapolla, A ^a   Sartore, G ^a   Rossetti, C ^a   Zambon, S ^a   Minicuci, N ^a   Crepaldi, G ^a   Fedele, D ^a   Manzato, E ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Clinica Medica V   (Italy)

Author keywords

Apoproteins; Coronary heart disease; Diabetes; Lipoproteins; Risk factors

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; C PEPTIDE; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; APOLIPOPROTEIN C; APOPROTEIN; GLYCOSYLATED HEMOGLOBIN; LIPOPROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL ANALYSIS; AGE; BLOOD; CORONARY ARTERY DISEASE; DIET RESTRICTION; MIDDLE AGED; SMOKING;

AGE FACTORS; AGED; APOLIPOPROTEIN A-II; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; APOPROTEINS; C-PEPTIDE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 2342427537     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(03)80167-9     Document Type: Article

References (20)

1. Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570-2581
2. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörä lä K (1990) 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 82: 27-36
3. Laakso M, Lehto S, Penttilä I, Pyörälä K (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88: 1421-1430
4. Manzato E, Zambon A, Lapolla A, Zambon S, Braghetto L, Crepaldi G, Fedele D (1993) Lipoprotein abnormalities in well-treated type II diabetic patients. Diabetes Care 16: 469-475
5. Roschlau VP, Bernt E, Gruber W (1974) Enzymatische bestimmung des gesamt-cholesterins im serum. Klin Chem Klin Biochem 12: 403-407
6. nd English ed, p 1831
7. Huggett AS, Nixon DA (1957) Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet 2: 368-370
8. Jaynes PK, Willis MC, Chou PP (1985) Evaluation of a mini-column chromatographic procedure for the measurement of hemoglobin A1c. Clin Biochem 18: 32-36
9. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN (1983) Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J 287: 863-867
10. Dati F (1989) Referenzwerte fur 18 plasmaproteine am Behing-Nephelometer- System. Lab Med 8: 87-90
11. Melani F, Rubenstein AH, Oyer PE, Steiner DF (1970) Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc Natl Acad Sci USA 67: 148-155
12. Stewart MW, Laker MF, Alberti KG (1994) The contribution of lipids to coronary heart disease in diabetes mellitus. J Intern Med 236 (Suppl 736): 41-46
13. Syvänne M, Taskinen MR (1997) Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350 (suppl 1): 20-23
14. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hörmann A, Holle R (1996) Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39: 1540-1545
15. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316: 823-828
16. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325: 373-381
17. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
18. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease - The Framingham Offspring Study. JAMA 272: 1666-1671
19. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91: 265-269
20. Kuusisto J, Mykkänen L, Kervinen K, Kesäniemi A, Laakso M (1995) Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 15: 1280-1286